Recent articles
2 High-Risk, High-Reward Stocks for Contrarian Investors
Feeling adventurous?
2 Growth Stocks Near 52-Week Lows to Buy Right Now
It's been a challenging year for these two companies.
2 Under-the-Radar Biotech Stocks to Buy in 2022
Don't overlook these two promising companies.
Can This Cancer Stock Maintain Its Momentum?
This biotech stock has been on fire since the beginning of the year.
Is It Too Late to Buy AbbVie Stock?
The bears think it's time to take profits and leave. But are they right?
Nasdaq Bear Market: 2 Growth Stocks to Buy on the Dip
The market may have overreacted to these companies' issues.
2 Stocks With 75% to 183% Upside, According to Wall Street
These two companies have been southbound lately.
Where Will Ocugen Be in 1 Year?
Can the company return to its 2021 highs?
2 Dividend Stocks to Boost Your Passive Income
Despite challenging economic conditions, these companies are unlikely to cut their dividends.
2 Red Flags for Gilead Sciences' Future
Consider these issues before buying shares of the drugmaker.
2 No-Brainer Pharma Stocks to Buy Right Now
Bristol-Myers Squibb and Johnson & Johnson have a lot to offer investors.
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
Despite struggles in the stock market, it's not all doom and gloom for these companies.
Could Novavax Stock Help You Retire a Millionaire?
This biotech company isn't just a COVID-19 play.
2 Beaten-Down Tech Stocks That Are Ready to Rebound
These two companies reported encouraging first-quarter results.
2 Healthcare Stocks That Could Make You Richer
The long-term outlook seems great for both of these companies.
Here's My Top Pharma Stock to Buy in May
This company has been flying high over the past 12 months.
2 Marijuana Stocks You Can Buy and Hold for the Next Decade
Unlike many of their peers in the cannabis industry, these two companies are consistently profitable.
1 Top Dividend Stock to Buy and Hold Forever
Investors can rest easy with this trusty healthcare giant and its 3% dividend yield.
2 Small-Cap Stocks With Monster Upsides, According to Wall Street
Sometimes analysts are on the spot, and other times, not so much.
2 Biotech Stocks to Buy and Hold for 10 Years
These two companies have moved in opposite directions on the stock market so far this year, but now seem set to move up and to the right.